June 8 - 9, 2011    Filadelfia PA , Stati Uniti
DISEASE MODIFICATION TARGETS

Translational Control of alpha-Synuclein: New Treatment for Parkinson’s Disease

Targeting Nuclear Hormone Receptors to Treat Neurodegenerative Disease

MOUSE MODELS

Mitopark Mice: A Model of Progressive Dopamine Depletion and Parkinsonism

IMAGING

Animal Model of Presymptomatic Parkinson’s Diseases

BIOMARKERS
Is Modulating Synuclein Phosphorylation a Potential Disease Modifying Approach for Parkinson’s Disease?

TARGETING SYMPTOMS OF PARKINSON’S
Novel mGluR4 Positive Allosteric Modulators in Parkinson’s Disease

Sede

Location: Sheraton Philadelphia City Center Hotel
Contatta 17th & Race St. Philadelphia , USA

Eventi correlati

Targeting Parkinson's Disease June 4 - 6, 2013
Targeting Parkinson's Disease 4 June, 2012
Targeting Parkinson's Disease June 8 - 9, 2011